RCKT insider buying and SEC filings, explained
Rocket Pharmaceuticals, Inc. · CIK 1281895
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$34K
Insiders who bought
1
Sold (not marked 10b5-1)
$692K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 11, 2026 | Sale | Martin Wilson (General Counsel) sold 75,364 shares at $3.40 ($256K). Holdings down 11% to 598,489 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 15, 2026 |
| Aug 18, 2026 | Sale | Martin Wilson (General Counsel) sold 631 shares at $3.38 ($2K). Holdings down <1% to 673,853 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| Aug 18, 2026 | Sale | Gaurav Shah (CEO) sold 2,293 shares at $3.38 ($8K). Holdings down <1% to 1,056,594 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| Aug 13, 2026 | Sale | Gaurav Shah (CEO) sold 2,837 shares at $3.38 ($10K). Holdings down <1% to 1,058,887 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 17, 2026 |
| Aug 13, 2026 | Sale | Martin Wilson (General Counsel) sold 3,493 shares at $3.38 ($12K). Holdings down 1% to 674,484 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 17, 2026 |
| Aug 11, 2026 | Sale | Christopher James Stevens (President / COO) sold 36,658 shares at $3.50 ($128K). Holdings down 7% to 505,784 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 13, 2026 |
| Aug 11, 2026 | Sale | Sarbani Chaudhuri (Officer) sold 4,701 shares at $3.50 ($16K). Holdings down 2% to 262,809 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 13, 2026 |
| May 19, 2026 | Sale | Gaurav Shah (CEO) sold 2,409 shares at $3.01 ($7K). Holdings down <1% to 1,040,918 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 21, 2026 |
| May 19, 2026 | Sale | Martin Wilson (General Counsel) sold 662 shares at $3.01 ($2K). Holdings down <1% to 677,977 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 21, 2026 |
| May 19, 2026 | Sale | John Militello (Officer) sold 384 shares at $3.01 ($1K). Holdings down <1% to 89,780 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 21, 2026 |
| May 13, 2026 | Sale | Martin Wilson (General Counsel) sold 3,361 shares at $3.61 ($12K). Holdings down <1% to 678,639 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 14, 2026 |
| May 13, 2026 | Sale | Gaurav Shah (CEO) sold 2,728 shares at $3.61 ($10K). Holdings down <1% to 1,043,327 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 14, 2026 |
| May 13, 2026 | Sale | John Militello (Officer) sold 855 shares at $3.61 ($3K). Holdings down 1% to 90,164 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 14, 2026 |
| May 7, 2026 | Sale | Sarbani Chaudhuri (Officer) sold 17,650 shares at $3.84 ($68K). Holdings down 6% to 267,510 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 11, 2026 |
| Feb 18, 2026 | Sale | John Militello (Officer) sold 1,157 shares at $3.34 ($4K). Holdings down 1% to 91,019 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 20, 2026 |
| Feb 18, 2026 | Sale | Gaurav Shah (CEO) sold 5,990 shares at $3.34 ($20K). Holdings down 1% to 1,046,055 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 20, 2026 |
| Feb 18, 2026 | Sale | Martin Wilson (General Counsel) sold 1,376 shares at $3.34 ($5K). Holdings down <1% to 682,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 20, 2026 |
| Feb 13, 2026 | Sale | Martin Wilson (General Counsel) sold 12,253 shares at $3.31 ($41K). Holdings down 2% to 683,376 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 18, 2026 |
| Feb 13, 2026 | Sale | John Militello (Officer) sold 3,726 shares at $3.31 ($12K). Holdings down 4% to 92,176 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 18, 2026 |
| Feb 13, 2026 | Sale | Gaurav Shah (CEO) sold 12,279 shares at $3.31 ($41K). Holdings down 1% to 1,052,045 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 18, 2026 |
| Jan 2, 2026 | Purchase (code P) | Elisabeth Bjork (Director) bought 10,000 shares at $3.44 ($34K), reported as a purchase (code P). Holdings up 25% to 50,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Nov 18, 2025 | Sale | John Militello (Officer) sold 1,086 shares at $2.98 ($3K). Holdings down 2% to 65,920 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
| Nov 18, 2025 | Sale | Jonathan David Schwartz (Officer) sold 2,545 shares at $2.98 ($8K). Holdings down 1% to 299,064 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
| Nov 18, 2025 | Sale | Gaurav Shah (CEO and Director) sold 6,276 shares at $2.98 ($19K). Holdings down 1% to 778,296 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
| Nov 18, 2025 | Sale | Martin Wilson (General Counsel) sold 1,646 shares at $2.98 ($5K). Holdings down <1% to 383,816 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
18 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RCKT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.